## Gene Summary
GABRB1, which stands for Gamma-Aminobutyric Acid Type A Receptor Beta1 Subunit, is a gene that encodes for a subunit of the GABA type A receptor. This receptor is a key mediator of the inhibitory neurotransmitter GABA in the central nervous system. GABRB1 contributes to the structure and functional regulation of the receptor, influencing inhibitory synaptic transmission in the brain. The geneâ€™s expression is particularly significant in areas involved in mood, cognition, and motor control.

## Gene Drugs, Diseases, Phenotypes, and Pathways
GABRB1 has been implicated in a variety of neuronal and psychiatric conditions. It is associated with disorders like epilepsy, anxiety, insomnia, and schizophrenia. The dysfunction or abnormal regulation of gene expression can impact synaptic transmission and neurodevelopment, leading to these diseases. GABRB1 plays a critical role in the GABAergic signaling pathway, a major inhibitory mechanism that balances neuronal excitability and responsiveness, which can contribute to different phenotypic manifestations when dysregulated.

## Pharmacogenetics
In pharmacogenetics, GABRB1 has been studied for its influence on responses to drugs targeting the GABAergic system. Compounds like benzodiazepines, which are used in the treatment of anxiety and insomnia, act by modulating the GABA_A receptors. Variability in the GABRB1 gene might impact the efficacy and safety of these therapies, potentially influencing dose requirements and risk of side effects. Understanding the genetic variations within GABRB1 could lead to more personalized and effective treatment strategies for neurological and psychiatric disorders.